PEOPLE ON THE MOVE
Greenphire
Greenphire, a company offering payment technology for clinical trials, has appointed Jim Murphy CEO. Murphy, who previously served as president and managing director of Almac Clinical Technologies, has been tasked with scaling up the company’s operations.
"Since its founding in 2008, Greenphire's electronic clinical trial payment solutions have been used to support more clinical studies than all our competitors combined,” claimed Greenphire co-founder Samuel Whitaker. "To continue our success, it is my view that a new skill set was needed in the CEO role, one that is deep in clinical technology experience and refined through past management of organizational growth. I have known Jim Murphy as a Greenphire supporter and friend for many years and I am delighted that he has accepted the role.”